Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Zhai, Hua Ling ^a   Wu, Hui ^a   Xu, Hui ^a   Weng, Pan ^a   Xia, Fang Zhen ^a   Chen, Yi ^a   Lu, Ying Li ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Andronate; Glucose metabolism; High fat diet; Lipid metabolism; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; GLYCEROL; INSULIN; ISOTOPE; LIPID; SEX HORMONE; TESTOSTERONE PROPIONATE; ANDROGEN; CARBON; DEUTERIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; TESTOSTERONE; TESTOSTERONE 17 BETA CYPIONATE; TESTOSTERONE 17 BETA-CYPIONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; RAT; REPRODUCTION; ANIMAL; BIOLOGICAL MODEL; BLOOD; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HAIR; HOMEOSTASIS; METABOLISM; SPRAGUE DAWLEY RAT;

MUS; RATTUS;

ANDROGENS; ANIMALS; BLOOD GLUCOSE; CARBON ISOTOPES; DEUTERIUM; DIET, HIGH-FAT; ESTROUS CYCLE; FEMALE; HAIR; HOMEOSTASIS; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MODELS, BIOLOGICAL; POLYCYSTIC OVARY SYNDROME; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

EID: 84856093677     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-5     Document Type: Article

References (27)

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005, 352(12):1223-1236. 10.1056/NEJMra041536, 15788499.
2. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007, 370:685-697. 10.1016/S0140-6736(07)61345-2, 17720020.
3. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006, 65:137-145.
4. Nelson VL, Qin K-N, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss JF, McAllister JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86:5925-5933. 10.1210/jc.86.12.5925, 11739466.
5. Soule SG. Neuroendocrinology of the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 1996, 10(2):205-219. 10.1016/S0950-351X(96)80071-1, 8773745.
6. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999, 84(1):165-169. 10.1210/jc.84.1.165, 9920077.
7. Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996, 81(3):942-947. 10.1210/jc.81.3.942, 8772555.
8. Acién P, Quereda F, Matallín P, Villarroya E, López-Fernández JA, Acién M, Mauri M, Alfayate R. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 1999, 72:32-40. 10.1016/S0015-0282(99)00184-3, 10428145.
9. Traub ML. Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes 2011, 2(3):33-40. 10.4239/wjd.v2.i3.33, 3083905, 21537458.
10. Radavelli-Bagatini S, Blair AR, Proietto J, Spritzer PM, Andrikopoulos S. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function. J Endocrinol 2011, 209(3):307-315. 10.1530/JOE-11-0022, 21429962.
11. El-Mazny A, Abou-Salem N, El-Sherbiny W, El-Mazny A. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynaecol Obstet 2010, 109:239-241. 10.1016/j.ijgo.2010.01.014, 20199774.
12. Bouglé D, Zunquin G, Sesbouë B, Sabatier JP. Relationships of cardiorespiratory fitness with metabolic risk factors, inflammation, and liver transaminases in overweight youths. Int J Pediatr 2010, 2010:1-5.
13. Lu YL, Jiang BR, Xia FZ, Zhai HL, Chen Y, Yu J, Zhao LJ, Wang NJ, Qiao J, Yang LZ. Changes of pituitary and penile structure in male adult rats following castration and high-fat diet. J Endocrinol Invest 2011, 34(2):111-116.
14. Freeman R, Pollack R, Rosenbloom E. Assessing impaired glucose tolerance and insulin resistance in Polycystic Ovarian Syndrome with a muffin test: alternative to glucose tolerance test. Endocr Pract 2010, 16(5):810-817. 10.4158/EP09330.OR, 20439247.
15. American Diabetes Association Consensus development conference on insulin resistance. Diabetes Care 1998, 21:310-314. American Diabetes Association.
16. Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2010, 122:42-52. 10.1016/j.jsbmb.2009.12.010, 20036327.
17. Pesant MH, Baillargeon JP. Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome. Fertil Steril 2011, 95:210-215. 10.1016/j.fertnstert.2010.06.036, 20655529.
18. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nakama Y, Kagawa E, Dai K, Ootani T, Ikenaga H, Morimoto Y, Ejiri K, Oda N. Glucometabolic responses during glucose tolerance test: a comparison between known diabetes and newly detected diabetes after acute myocardial infarction. Int J Cardiol 2011, 152(1):78-82. 10.1016/j.ijcard.2010.07.009, 20674993.
19. Manni L, Cajander S, Lundeberg T, Naylor AS, Aloe L, Holmäng A, Jonsdottir IH, Stener-Victorin E. Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries. J Neuroendocrinol 2005, 17(12):846-858.
20. Kafali H, Iriadam M, Ozardali I, Demir N. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res 2004, 35(2):103-108. 10.1016/j.arcmed.2003.10.005, 15010188.
21. Mannerås L, Cajander S, Holmäng A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007, 148(8):3781-3791. 10.1210/en.2007-0168, 17495003.
22. Minassian C, Tarpin S, Mithieux G. Role of Glucose-6 Phosphatase, Glucokinase, and Glucose-6 Phosphate in Liver Insulin Resistance and Its Correction by Metformin. Biochem Pharmacol 1998, 55:1213-1219. 10.1016/S0006-2952(97)00576-5, 9719475.
23. Acién P, Quereda F, Matallín P, Villarroya E, López-Fernández JA, Acién M, Mauri M, Alfayate R. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril 1999, 72:32-40. 10.1016/S0015-0282(99)00184-3, 10428145.
24. Luque-Ramírez M, Alpañés M, Escobar-Morreale HF. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism. Fertil Steril 2010, 94:2214-2221. 10.1016/j.fertnstert.2009.11.049, 20097337.
25. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006, 91:492-497.
26. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295:1288-1299. 10.1001/jama.295.11.1288, 16537739.
27. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE, Herkimer C. Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 2010, 151:595-605. 10.1210/en.2009-1015, 2817622, 19966179.